Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clin Genitourin Cancer. 2016 12; 14(6):511-517.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Transitional Cell
Cisplatin
Female
Germ-Line Mutation
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Pharmacogenomic Variants
Polymorphism, Single Nucleotide
Survival Analysis
Treatment Outcome

authors with profiles

Walter M. Stadler
Peter H. O'Donnell
Hongyuan Cao